Dose Effects of LAB on Modulation of Rotavirus Vaccine Induced Immune Responses by Yuan, Lijuan et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 11 
 
 
 
 
© 2013 Yuan et al., licensee InTech. This is an open access chapter distributed under the terms of the 
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Dose Effects of LAB on Modulation of  
Rotavirus Vaccine Induced Immune Responses 
Lijuan Yuan, Ke Wen, Fangning Liu and Guohua Li 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/50379 
1. Introduction 
Probiotics can influence both mucosal and systemic immune responses and function as 
adjuvants by promoting proinflammatory cytokine production, enhancing both humoral 
and cellular immune responses. Adjuvant effects of several probiotic lactic acid bacteria 
(LAB), mostly Lactobacillus strains, including L. rhamnosus GG, L. acidophilus NCFM, L. 
acidophilus CRL431, L. acidophilus La-14, L. fermentum CECT5716, L. casei DN-114 001, and 
Bifidobacterium lactis Bl-04 have been reported in studies of influenza, polio, rotavirus and 
cholera vaccines and rotavirus and Salmonella typhi Ty21a infections (Boge et al., 2009; 
Davidson et al., 2011; Isolauri et al., 1995; Kaila et al., 1992; Mohamadzadeh et al., 2008; 
Olivares et al., 2007; Paineau et al., 2008; Winkler et al., 2005; Zhang et al., 2008b). The word 
adjuvant in the phrase “probiotic adjuvant” is not used in its traditional definition in which 
adjuvant implies a substance included in the vaccine formulation to aid the immune 
response to the vaccine antigen. Instead, probiotic adjuvants enhance the immunogenicity of 
vaccines when orally administered repeatedly around the time of vaccination and separately 
from the vaccine. By skewing the balance of pro- and anti-inflammatory innate immune 
responses and T helper (Th) 1 and regulatory T (Treg) cell adaptive immune responses in 
the context of vaccination, probiotic adjuvants act as “signal zero” to reduce Treg cell 
suppression and unleash effector T cell activation (Rowe et al., 2012). 
Although the strain-specific effects of LAB in up- or down-regulating inflammatory immune 
responses have been well recognized, dose effects of probiotics on innate and adaptive 
immune responses are not clearly understood. The same Lactobacillus strain is oftentimes 
reported by different research groups to have opposite immune modulating effects. We 
hypothesized that the dose effect is at least one of the reasons for the conflicting reports. 
Understanding dose effects of probiotics has significant implications in their use as 
immunostimulatory (adjuvants) versus immunoregulatory agents. 
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In this chapter, we discuss findings from our serial studies of gnotobiotic pigs on the dose 
effects of the L. acidophilus NCFM strain (LA) on innate and adaptive immune responses 
induced by an oral attenuated human rotavirus (HRV) vaccine (AttHRV). We studied the 
effects of low dose (total 2.11 x 106 CFU) and high dose (total 2.22 x 109 CFU) LA on the 
intestinal and systemic (1) rotavirus-specific IFN-γ producing CD4+ and CD8+ T cell 
responses; (2) CD4+CD25+FoxP3+ and CD4+CD25-FoxP3+ Treg cell responses and the 
regulatory cytokine TGF-β and IL-10 production; (3) rotavirus-specific antibody-secreting 
cell (ASC) and serum antibody responses; and (4) plasmacytoid dendritic cell (pDC) and 
conventional DC (cDC) frequencies, activation status, TLR expression and cytokine 
production profile. The protective effect of rotavirus vaccine against virus shedding and 
diarrhea was assessed in AttHRV-vaccinated gnotobiotic pigs fed with high, low, or no LA 
and challenged with the virulent HRV.  
These studies clearly demonstrated differential immune modulating effects of high dose 
versus low dose LA on DC and T cell responses, and consequently different effects on the 
protection conferred by the AttHRV vaccine in gnotobiotic pigs challenged with virulent 
HRV. Low dose LA enhanced the protection against rotavirus diarrhea in AttHRV-
vaccinated pigs whereas high dose LA had negative effects on the effectiveness of the 
vaccine. Thus, the same probiotic strains at different doses can exert qualitatively different 
modulating effects on immune responses induced by rotavirus vaccines and possibly other 
vaccines as well.  
2. Dose effects of LA on T cell responses 
Probiotics have been reported to exert adjuvant properties by inducing pro-Th1 cytokines 
and promote Th1 type immune responses. For example, L. lactis and L. plantarum induced 
production of IL-12 and IFN-γ by splenocytes when the LAB and an allergen were co-
administered intranasally to mice (Repa et al., 2003). L. fermentum strain CECT5716 
enhanced the Th1 responses induced by an influenza vaccine in addition to enhancing virus 
neutralizing antibody responses (Olivares et al., 2007). Eleven different probiotic strains 
were tested for cytokine production in human peripheral blood mononuclear cells (MNC) 
and each tested bacterium was shown to induce production of TNF-α and some strains also 
induced production of IL-12 and IFN-γ (Kekkonen et al., 2008). Previous studies of 
gnotobiotic pigs showed that a mixture of LA NCFM strain and L. reuteri strain enhanced 
both Th1 (IL-12, IFN-γ) and Th2 (IL-4 and IL-10) cytokine responses to virulent HRV 
infection (Azevedo et al., 2012). LA NCFM strain enhanced the HRV-specific IFN-γ 
producing CD8+ T cell response to a rotavirus vaccine in gnotobiotic pigs, indicating 
adjuvanticity of the LA strain (Zhang et al., 2008b).  
Dose effects of probiotics on modulating T cell immune responses have not been well 
studied. To address this question, we examined the dose effects of LA NCFM (NCK56) 
strain on IFN-γ producing CD4+ and CD8+ T cell immune responses induced by an oral 
rotavirus vaccine in gnotobiotic pigs (Wen et al., 2012). The animal treatment groups 
included (1) high dose LA plus AttHRV vaccine (HiLA+AttHRV), (2) low dose LA plus 
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AttHRV (LoLA+AttHRV), (3) AttHRV only, (4) high dose LA only (HiLA), (5) low dose LA 
only (LoLA), and (6) mock-inoculated control (Mock). Gnotobiotic pigs were orally 
inoculated at 5 days of age with the AttHRV vaccine at 5 x107 fluorescent focus-forming 
units (FFU) per dose. A booster dose was given 10 days later at the same dose and route. 
Subsets of the pigs were euthanized at post-inoculation day (PID) 28 to assess immune 
responses and the rest were challenged with the homotypic virulent Wa (G1,P1A[8]) strain 
HRV at a dose of 1 x 105 FFU to assess protection from post-challenge day (PCD) 1 to 7. The 
50% infectious dose and 50% diarrhea dose of the virulent HRV in gnotobiotic pigs are 
approximately 1 FFU (Ward et al., 1996). The AttHRV inoculation causes virus shedding in 
about 6% pigs, but it does not cause any illness (Ward et al., 1996). Pigs in the high dose LA 
groups were fed daily with 103 to 109 CFU/dose of LA for 14 days with 10-fold incremental 
dose increases every other day from 3-16 days of age. The accumulative total LA dose was 
2.22 x 109 CFU. Pigs in the low dose LA groups were fed with 103, 104, 105, 106, and 106 
CFU/dose of LA every other day from 3-11 days of age. The accumulative total LA dose was 
2.11 x 106 CFU. 
2.1. Low dose LA, but not high dose LA, enhanced HRV-specific IFN-γ 
producing T cell responses 
The magnitude of HRV-specific IFN-γ producing T cell responses in pigs was differentially 
modulated by low versus high dose LA at both prechallenge and postchallenge (PID 28 and 
PCD 7). AttHRV-vaccinated and low dose LA fed pigs (LoLA+AttHRV) had significantly 
higher frequencies of HRV-specific IFN-γ+CD8+ T cells in ileum (11- and 5-fold higher pre- 
and postchallenge, respectively), spleen (3.8- and 2.1-fold higher pre- and postchallenge, 
respectively) and blood (3- and 20-fold higher pre- and postchallenge, respectively) 
compared to the AttHRV only pigs (Table 1). The LoLA+AttHRV pigs also had significantly 
higher frequencies of HRV-specific IFN-γ+CD4+ T cells in blood (3-fold higher for both pre- 
and postchallenge) compared to the AttHRV only pigs. In contrast, high dose LA did not 
significantly alter the HRV-specific IFN-γ producing CD4+ and CD8+ T cell responses in the 
HiLA+HRV pigs compared to AttHRV only pigs.  
 
  Frequencies of IFN-γ+CD8+ T cells among CD3+ cells 
   PID 28    PCD 7  
  Ileum Spleen Blood  Ileum Spleen Blood 
HiLA+AttHRV 0.05 0.34 0.05  0.11 0.16 0.06 
LoLA+AttHRV 1.21 0.46 0.24  0.56 0.46 0.98 
AttHRV only  0.11 0.12 0.08  0.11 0.22 0.05 
(Summarized from Wen et al., 2012) 
Table 1. Effect of low dose vs. high dose LA on IFN-γ producing CD8+ T cell responses 
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2.2. High dose LA significantly increased frequencies of intestinal and systemic 
CD4+CD25-FoxP3+ Treg cells whereas low dose LA decreased TGF-β and IL-10 
producing Treg cell responses 
Frequencies and cytokine production of Treg cells in pigs were differentially modulated by 
low versus high dose LA at both prechallenge and postchallenge. HiLA+AttHRV pigs had 
significantly higher frequencies of CD4+CD25-FoxP3+ Treg cells (ranging from 6- to 86-fold 
higher) in all the tissues compared to LoLA+AttHRV and AttHRV only pigs pre- and 
postchallenge (Table 2). 
Because Treg cells exert regulatory functions through mechanisms involving TGF-β and IL-
10, we also compared the effects of high and low dose LA on frequencies of the Treg cell 
subsets that produced TGF-β or IL-10 among the AttHRV-vaccinated pigs.  
 
  Frequencies of CD4+CD25-FoxP3+Treg cells among total MNC 
   PID 28    PCD 7  
  Ileum Spleen Blood  Ileum Spleen Blood 
HiLA+AttHRV 2.96  10.34 9.00   1.56  3.78 3.65  
LoLA+AttHRV 0.24  0.54 0.10   0.08  0.22 0.05  
AttHRV only  0.23 0.59 0.51  0.27  0.26 0.17  
(Summarized from Wen et al., 2012) 
Table 2. Effect of low dose vs. high dose LA on frequencies of Treg cells 
Low dose LA reduced frequencies of TGF-β producing CD4+CD25+FoxP3+ and CD4+CD25-
FoxP3+ Treg cells compared to high dose LA and AttHRV only pigs in all tissues pre- and 
postchallenge (Table 3; data for CD25+ Treg cells are not shown). Low dose LA also reduced 
pre- and postchallenge frequencies of IL-10 producing CD4+CD25+FoxP3+ and CD4+CD25- 
FoxP3+Treg cells compared to high dose LA and AttHRV- only (except for CD4+CD25-
FoxP3+ Treg cells in ileum and spleen postchallenge) (Table 3). High dose LA induced 2.6-
fold and 20-fold, respectively higher frequencies of IL-10 producing CD4+CD25-FoxP3+ 
Treg cells in ileum and spleen postchallenge compared to AttHRV only.  
 
  PID 28   PCD 7  
 Ileum Spleen Blood  Ileum Spleen Blood 
 Frequencies of TGF-β+ cells among CD4+CD25-FoxP3+ Treg cells 
HiLA+AttHRV 4.51  1.13 0.92   4.87  10.05 1.39  
LoLA+AttHRV 0.32  0.15 0.31   0.00  0.17 0.38  
AttHRV only 4.19  1.19 1.55  4.34 0.79 1.53 
 Frequencies of IL-10+ cells among CD4+CD25-FoxP3+ Treg cells 
HiLA+AttHRV 4.21  2.97 0.88   10.68 17.70 2.51  
LoLA+AttHRV 0.92  0.15 0.00   5.22  6.79 0.00  
AttHRV only 4.47  3.01 1.77  4.08 0.90 1.44 
(Summarized from Wen et al., 2012) 
Table 3. Effect of low dose vs. high dose LA on CD25-FoxP3+ Treg cell cytokine production  
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These data clearly demonstrated that low dose LA promoted IFN-γ producing T cell and 
down-regulated Treg cell responses, whereas high dose LA induced a strong Treg cell 
response and promoted the regulatory cytokine production by tissue-residing Treg cells 
postchallenge in gnotobiotic pigs. Studies of other lactobacilli strains have reported similar 
findings. A mixture of L. plantarum CEC 7315 and CEC 7316 at high dose (5×109 CFU/day) 
resulted in significant increases in the percentages of activated potential T-suppressor and 
NK cells, while at low dose (5×108 CFU/day) increased activated T-helper cells, B cells and 
antigen presenting cells (APCs) in institutionalized seniors (Mane et al., 2011). High 
concentration (≥ 1×106 colony forming unit [CFU]/ml) of a combination containing LA and 
Bifidobacterium or B. infantis attenuated mitogen-induced immune responses by inhibiting 
cell proliferation and arresting the cell cycle at the G0/G1 stage in both mitogen-stimulated 
spleen cells and peripheral blood MNC. However, low concentration (≤ 1×106 CFU/ml) 
promoted a shift in the Th1/Th2 balance toward Th1-skewed immunity by enhancing IFN-γ 
and inhibiting IL-4 response (Li et al., 2011). The differences between the “low dose” and 
“high dose” LAB in these studies are small, yet the immunomodulatory effects are 
qualitatively different. 
Dose effects may explain some of the controversies that result from the same probiotic strain 
used by different research groups in animal studies showing opposite immunomodulatory 
functions. For example, administration of L. casei suppressed pro-inflammatory cytokine 
expression by CD4+ T cells and up-regulated IL-10 and TGF-β levels in rats (So et al., 2008a; 
So et al., 2008b). On the contrary, another study found that L. casei was a pure Th1 inducer in 
mice. In addition to the difference in animal species, the L. casei doses used by the different 
studies differed significantly, with much higher doses used in the studies of rats (So et al., 
2008a; So et al., 2008b). In the studies of rats, the amount of L. casei was 5 × 109 or 2 x1010 
CFU/dose per rat, three times per week for 11-12 weeks. In the study of mice, the amount of 
L. casei was 2 x 108 CFU/dose per mouse, twice per week for 8 weeks (Van Overtvelt et al., 
2010). Thus, different dose and frequency of administration of the same LAB strains may 
result in totally different in vivo effects. 
The dose effects of LA on immune responses to the AttHRV vaccine in pigs may also partly 
explain why the efficacies of oral rotavirus vaccines are significantly reduced in low-income 
countries compared to developed countries. The two licensed rotavirus vaccines, RotaTeq 
and Rotarix have a protective efficacy of >85% against moderate to severe rotavirus 
gastroenteritis in middle and high-income countries (O'Ryan et al., 2009). However, the 
protective efficacy of RotaTeq vaccine is only 39.3% against severe rotavirus gastroenteritis 
in sub-Saharan Africa (Armah et al., 2010) and 48.3% in developing countries in Asia 
(Zaman et al., 2010). Rotarix vaccine showed a similar disparity in efficacy in low-income 
countries in Africa (O'Ryan & Linhares, 2009). In addition to other factors that contribute to 
the reduction in rotavirus vaccine efficacy (e.g., higher titers of maternal antibodies, 
malnutrition), during the initial colonization of human infants, exposure to high doses of 
commensal bacteria (common in countries with lower hygiene standards) would have a 
suppressive effect on IFN-γ producing T cell responses and promote Treg cell responses, 
thus leading to the lowered protective immunity after rotavirus vaccination. 
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3. Dose effects of LA on antibody and B cell responses 
Probiotics are known to modulate both humoral and cellular immune responses. Probiotics 
can induce antigen-specific and non-specific IgA antibody responses at mucosal surfaces 
(Perdigon et al., 2001; Wells & Mercenier, 2008) to prevent invasion by pathogenic 
microorganisms. Oral administration of L. acidophilus L-92 strain led to a significant increase 
of IgA production in Peyer's patches in mice (Torii et al., 2007). L. casei CRL 431 strain 
increased induction of intestinal IgA secreting cells in mice (Galdeano & Perdigon, 2006). L. 
acidophilus La1 strain and bifidobacteria enhanced specific serum IgA titers to S. typhi strain 
Ty21a and also total serum IgA in humans (Link-Amster et al., 1994). L. rhamnosus GG 
enhanced rotavirus-specific IgA ASC responses in humans and promoted recovery from 
rotavirus diarrhea (Kaila et al., 1992). In our earlier study of gnotobiotic pigs, a mixture of 
LA strain and L. reuteri strain did not alter virus-specific intestinal and systemic antibody 
and ASC responses, but they significantly enhanced total intestinal IgA secreting cell 
responses and total serum IgM and intestinal IgM and IgG titers in rotavirus infected pigs 
(Zhang et al., 2008a).  
The first reported adjuvant effect of probiotic LAB in vaccination was from a human clinical 
trial in which L. rhamnosus GG was shown to enhance rotavirus-specific IgM secreting cells 
and rotavirus IgA seroconversion in infants receiving a live oral rhesus-human rotavirus 
reassortant vaccine (Isolauri et al., 1995). In recent years, an increasing number of human 
clinical trials have demonstrated adjuvant effects of probiotics in enhancing vaccine-induced 
antibody responses. In a double-blind randomized controlled trial, L. rhamnosus GG or L. 
acidophilus CRL 431 increased serum poliovirus neutralizing antibody titers and poliovirus-
specific IgA and IgG titers 2- to 4-fold in adult human volunteers vaccinated with the live 
oral polio vaccine (de Vrese et al., 2005). In another human clinical trial, six out of the seven 
probiotic strains tested enhanced cholera-specific IgG antibody concentration in serum; for 
the B. lactis Bl-04 and L. acidophilus La-14 strains the increase was more significant (Paineau 
et al., 2008). Daily consumption of a fermented dairy drink (L. casei DN-114 001 and yoghurt 
ferments, Actimel) was shown to increase virus specific antibody responses to the 
intramuscular inactivated influenza vaccine in individuals of over 70 years of age (Boge et 
al., 2009). In a randomized, double-blind placebo-controlled pilot study, L. rhamnosus GG 
significantly improved the development of serum antibody responses to the H3N2 strain 
influenza virus (84% receiving L. rhamnosus GG versus 55% receiving placebo had a protective 
titer 28 days after vaccination) in healthy adults receiving the live attenuated influenza vaccine 
(FluMist, Medimmune Vaccines, Gaithersburg, MD, USA) (Davidson et al., 2011). Thus, 
specific strains of probiotics can act as adjuvants to enhance humoral immune responses 
following not only mucosal (oral or intranasal) but also parenteral vaccination. Yet, dose 
effects of probiotics on antibodies responses have not been well studied. 
In our studies, we demonstrated that high dose LA did not significantly alter the HRV-
specific antibody responses whereas low dose LA had negative effects on the antibody 
responses. The effect of high and low dose LA NCFM strain on HRV-specific serum IgA and 
IgG antibody levels and HRV-specific ASC and memory B cell responses in the intestinal 
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and systemic lymphoid tissues of gnotobiotic pigs induced by rotavirus vaccination were 
examined. The animal treatment groups were the same as listed above in the studies of T 
cell responses. High dose LA did not significantly alter the HRV-specific antibody responses 
in serum and ASC responses in any tissue at PID 28 and PCD 7 in the AttHRV-vaccinated 
pigs (Figs 1 and 2), except to reduce the IgG ASC response in ileum of the mock-vaccinated 
pigs postchallenge (Fig. 2c). In contrast, low dose LA significantly reduced the HRV-specific 
IgA antibody titers at PID 7 and 14 (Fig. 1a) and reduced or significantly reduced IgG ASC 
responses in blood pre- and postchallenge as well as IgA ASC responses in spleen and blood 
postchallenge (Fig. 2a and 2b). Low dose LA also significantly reduced the IgA and IgG ASC 
responses in ileum of the mock-vaccinated pigs postchallenge (Fig. 2c). 
 
Figure 1. Rotavirus-specific serum IgA and IgG antibody responses in Gn pigs vaccinated with AttHRV 
with or without high or low dose LA feeding. Rotavirus-specific serum IgA (a) and IgG (b) antibody 
were measured by an indirect isotype-specific antibody ELISA. Error bars indicate the standard error of 
the mean. Different capital letters (A, B) indicate significant difference among different pig groups at the 
same time point (Kruskal Wallis Test, p<0.05, n=3-27), whereas shared letters or no letters on top 
indicate no significant difference. 
The negative effects of low dose LA on the HRV-specific serum antibody responses and 
ASC responses induced by the AttHRV vaccine were undesirable for the vaccine’s 
immunogenicity; however it is consistent with the strong pro-Th1 effect of the low dose LA. 
The skewed balance toward a Th1 type immune response in the low dose LA group may 
have resulted in the weakened antibody responses. In the subsequent studies, we evaluated 
the effects of a low dose and an intermediate dose of L. rhamnosus GG on the effector T cell, 
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antibody and ASC responses induced by the AttHRV vaccine and we found that L. 
rhamnosus GG enhanced the production of a balanced Th1 and Th2 immune responses to the 
AttHRV vaccine and significantly increased the virus-specific IFN-γ producing T cell 
responses, the antibody responses and the protection rate of the AttHRV vaccine 
(manuscripts under preparation). 
 
Figure 2. Rotavirus-specific IgA and IgG ASC responses in Gn pigs. Rotavirus-specific IgA and IgG 
ASC in the MNC isolated from ileum, spleen and blood of AttHRV-vaccinated pigs on PID 28 (PCD 0) 
(a) and PID 35 (PCD 7) (b) and of mock-vaccinated pigs on PID 35 (PCD 7) (c) were enumerated by 
using an ELISPOT assay and are presented as the mean numbers of virus-specific IgA and IgG ASC per 
5×105 MNC. Error bars indicate the standard error of the mean. Different capital letters (A, B, C) on top 
of the bars indicate significant difference among the treatment groups for the same isotype in the same 
tissue (Kruskal Wallis Test, p<0.05, n=3-14), whereas shared letters or no letters on top indicate no 
significant difference. Note the y axis scale difference (HiLA, high dose LA; LoLA, low dose LA). 
4. Dose effects of LA on DC responses 
The nature and consequences of a CD4+ T cell response (Th1, Th2, Th17, or Treg type) 
largely depend on the immune functions of DCs, which are the professional antigen 
presenting cells that can prime and differentiate naive T cells. Both cDC and pDC are 
responsible for presenting microbial and dietary antigens to the adaptive immune systems, 
thereby influencing polarization of the adaptive immune response (Konieczna et al., 2012). 
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The pDC most effectively sense virus infections and are characterized by their capacity to 
produce large quantities of IFN-α and the pro-inflammatory cytokines IL-6 and TNF-α. 
These cytokines promote cDC maturation (Summerfield & McCullough, 2009). MHC II 
expression in professional APCs is tightly regulated. The MHC II of immature DCs are 
expressed at low levels at the plasma membrane, but abundantly in endocytic 
compartments. In the presence of inflammatory cytokines such as IFN-γ, DCs are activated; 
they stop capturing antigens and markedly increase MHC II expression on their plasma 
membrane. These MHC II are loaded with peptides derived from antigens captured at the 
site of inflammation. The mature DCs migrate to lymphoid tissues and up-regulate the co-
stimulatory molecules (CD80/86) necessary to activate naïve T cells (Villadangos et al., 2001).  
It is known that probiotics can modify the distribution, the phenotype and the function of 
DC subsets (Grangette, 2012). Both species-specific and strain-specific immunomodulatory 
effects of different LAB on DCs have been described in a large number of studies and was 
reviewed previously (Meijerink & Wells, 2010). Among the differential effects, several 
lactobacilli strains, including L. acidophilus, L. gasseri, L. fermentum, L. casei, L. plantarum, L. 
johnsonii, and L. rhamnosus have been reported to stimulate human or murine DCs to 
produce increased levels of proinflammatory cytokines (IL-2, IL-12, TNF-α) that favored Th1 
and cytotoxic T cell polarization, and decreased levels of the regulatory cytokine TGF-β 
(Chiba et al., 2010; Christensen et al., 2002; Mohamadzadeh et al., 2005; Van Overtvelt et al., 
2010; Vitini et al., 2000; Weiss et al., 2010; Yazdi et al., 2010). Such immune stimulating 
effects are characteristics of adjuvants. However, studies of dose effects of lactobacilli on DC 
responses are scarce, with most consisting of in vitro experiments, and there is a dearth of 
comparative studies linking in vitro and in vivo results. L. rhamnosus Lcr35 was shown to 
induce a dose-dependent immunomodulation of human DCs. Lcr35 at 107 CFU/ml (10 
multiplicity of infection), but not 104 CFU/ml induced the semi-maturation of the DCs and a 
strong pro-inflammatory response (Evrard et al., 2011). LA NCFM induced a concentration 
dependent production of IL-10, and low IL-12p70 in monocyte derived DCs (Konstantinov 
et al., 2008). Immature DCs incubated with the LA NCFM at a bacterium to cell ratio of 
1000:1 (“high dose”) produced significantly higher IL-10 compared with the ratio of 10:1. In 
contrast, IL-12p70 was up-regulated at a lower concentration of the bacterium (10:1).  
In our studies, dose effects of LA on pDC and cDC responses after rotavirus vaccination 
were examined in gnotobiotic pigs. The animal treatment groups were the same as listed 
earlier in the studies of T cell and B cell immune responses. Porcine pDC (CD172a+CD4+) 
and cDC (CD172a+CD11R1+) were defined as previously described (Jamin et al., 2006). The 
frequencies and tissue distribution, MHC II and costimulatory (CD80/86) molecular, TLR (2, 
3, 9) and cytokine (IL-6, IL-10, IFN-α, TNF-α) expression by pDC and cDC in ileum, spleen 
and blood of gnotobiotic pigs vaccinated with the AttHRV and fed with high dose, low dose 
or no LA were determined using multi-color flow cytometry. 
The low dose LA group had significantly higher frequencies of pDC in ileum and spleen 
and cDC in spleen and blood compared to the high dose LA and AttHRV only groups (Fig. 
3a). The low dose LA group had overall lower MHC II expression on pDC and cDC in all 
tissues and lower CD80/86 expression in blood, but significantly higher CD80/86 expression 
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on cDC in ileum, compared to the high dose LA and AttHRV only groups (Fig. 3b). High 
dose LA did not have a significant effect on DC frequencies or activation marker MHC II 
and CD80/86 expression, except for the significantly increased CD80/86 expression on pDC 
in ileum compared to the AttHRV only group (Fig. 3b). 
 
Figure 3. Frequencies of pDC and cDC (a) and the activation marker (CD80/86 and MHC II) expression 
(b) in intestinal and systemic lymphoid tissues of Gn pigs vaccinated with AttHRV vaccine with high 
dose, low dose or no LA at PID 28. MNC were stained freshly without in vitro stimulation before being 
subjected to flow cytometry analyses. Data are presented as mean frequency ± standard error of the 
mean (n = 3-13). Different letters on top of bars indicate significant differences in frequencies among 
groups for the same cell type and tissue (Kruskal–Wallis test, p < 0.05), while shared letters indicate no 
significant difference. 
The low dose LA group had lower or significantly lower frequencies of TLR3 expression in 
both pDC and cDC in all tissues and significantly lower TLR2 expression on cDC in spleen 
compared to the high dose LA and AttHRV only groups (Fig. 4). High dose LA did not have 
a significant effect on TLR expression in ileum and spleen. In blood, high dose LA group 
had significantly lower TLR3 expression in cDC (and lower in pDC) compared to the 
AttHRV only group.  
The most striking dose effect of LA on the cytokine production profile in DCs is the 
significantly increased IL-6 in the low dose LA group (Fig. 5). The low dose LA group had 
significantly higher frequencies of IL-6 producing pDC and cDC in all tissues compared to 
the high dose LA and AttHRV only groups. Interestingly, the low dose LA reduced or 
significantly reduced the other cytokine TNF-α, IL-10 and IFN-α production in pDC in 
ileum and spleen. In contrast to ileum and spleen, the low dose LA increased or significantly 
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increased TNF-α, IL-10 and IFN-α production in blood compared to the high dose LA or the 
AttHRV only group. High dose LA did not have a significant effect on IL-6, TNF-α, and IL-
10 but lowered or significantly lowered IFN-α production in both pDC and cDC in all 
tissues compared to the AttHRV only group.  
 
Figure 4. TLR expression patterns of pDC and cDC in intestinal and systemic lymphoid tissues of Gn 
pigs vaccinated with AttHRV vaccine with high dose, low dose or no LA at PID 28. MNC were stained 
freshly without in vitro stimulation before flow cytometry analyses. Data are presented as mean 
frequency ± standard error of the mean (n = 3-5). Different letters on top of bars indicate significant 
differences in frequencies among groups for the same TLR in the same tissue (Kruskal–Wallis test, p < 
0.05), while shared letters indicate no significant difference. 
Therefore, the effects of high versus low dose LA on the frequencies, maturation status and 
functions of DCs were strikingly different. Low dose LA significantly increased frequencies 
of both DC subsets, but these DCs were immature because they expressed lower frequencies 
of activation makers CD80/86 and MHC II and had reduced TNF-α, IL-10 and IFN-α 
production compared to the high dose LA and AttHRV only groups. Low dose LA 
promoted a strong IL-6 response in all tissues and increased all the other cytokine TNF-α, IL-
10 and IFN-α production in blood for both pDC and cDC. High dose LA did not have such a 
significant modulating effect on the DC responses compared to the low dose (with a few 
exceptions). These findings are consistent with the differential effects of low dose versus high 
dose LA on the adaptive immune responses. The differential modulating effects of high versus 
low dose LA are intriguing. The biological and immunological implications of these effects 
and the underlying mechanisms require further investigation. From these data, it is clear that 
the same probiotic strain at different doses can exert qualitatively different modulating effects 
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on DCs and consequently on adaptive immune responses induced by rotavirus vaccines. It has 
been reported that the effect of low dose microbe-associated pattern molecular (MAPM), such 
as lipopolysaccharide, was strikingly different as compared to that of high dose on 
macrophage cell functions: low dose lipopolysaccharide induced a strong inflammatory 
response in macrophages (Maitra et al., 2011). It is plausible that a similar interaction occurs 
between the MAPM from LA and DCs in the gut. Future studies are needed to identify the 
molecular mechanisms of the dose responses of different MAPM. 
 
Figure 5. Cytokine production profiles of pDC and cDC in intestinal and systemic lymphoid tissues of 
Gn pigs vaccinated with AttHRV vaccine with high dose, low dose or no LA at PID 28. MNC were 
stained freshly without in vitro stimulation before flow cytometry analyses. Data are presented as mean 
frequency ± standard error of the mean (n = 3-8). Different letters on top of bars indicate significant 
differences in frequencies among groups for the same cytokine in the same tissue (Kruskal–Wallis test, 
p < 0.05), while shared letters indicate no significant difference. 
5. Dose effects of LA on protection conferred by the oral AttHRV vaccine 
against virulent HRV challenge 
To examine the effects of low and high dose LA on improving the protection conferred by 
the AttHRV vaccine, subsets of gnotobiotic pigs from each treatment group were challenged 
with the virulent HRV Wa strain at PID 28. Clinical signs and virus shedding were 
monitored for 7 days postchallenge (Table 4). 
After challenge, although the proportion of pigs that developed virus shedding and 
diarrhea did not differ significantly among the three AttHRV vaccinated pig groups, the 
LoLA+AttHRV group had the shortest mean durations of fecal virus shedding and diarrhea 
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and the lowest mean cumulative fecal consistency score among all the treatment groups. 
The durations of diarrhea in the LoLA+AttHRV pigs were significantly shorter compared to 
the AttHRV only and the mock-vaccinated control pigs. The durations of virus shedding in 
the LoLA+AttHRV pigs were significantly shorter compared to the HiLA+AttHRV and the 
mock control pigs. The mean cumulative fecal consistency scores in all the pigs in the 
LoLA+AttHRV and AttHRV only groups (8.4 and 9.0, respectively) were significantly lower 
than the control group, indicating significant protection against the severity of diarrhea. 
Thus, low dose LA slightly, but clearly improved the protection conferred by the AttHRV 
vaccine against rotavirus diarrhea. In contrast, high dose LA reduced the protection 
conferred by the AttHRV vaccine as indicated by the significantly longer mean duration of 
virus shedding (3.8 versus 1.3 days) and higher mean cumulative fecal scores compared to 
the AttHRV only pigs. 
 
Treatments n Clinical signs  Fecal virus shedding  
(by CCIF and/or ELISA) 
% with 
diarrhea *,  a
Mean 
duration 
days **,  
Mean 
cumulative 
score ** , c 
 % shedding 
virus * 
Mean 
duration 
days ** 
Mean 
peak titer 
(FFU/ml) 
**, d 
HiLA+AttHRV 13 92 A 4.3 
(0.7b) AB 
12.5 
(1.4) AB 
 31 B 3.8 
(0.3) A 
2.0 B 
LoLA+AttHRV 8 88 A 2.4 
(0.7) B 
8.4 
(1.3) B 
 36 B 1.0 
(0.0) B 
5.6 B 
AttHRV only 12 67 A 4.6 
(0.5) A 
9.8 
(1.4) B 
 50 B 1.3 
(0.2) B 
4.9 B 
Mock control 9 100 A 5.6 
(0.3) A 
14.4 
(1.0) A 
 100 A 4.7 
(0.7) A 
4558 A 
∆ The data was partially presented previously (Wen et al., 2012). 
a  Pigs with daily fecal scores of  ≥2 were considered diarrheic. Fecal consistency was scored as follows: 0, normal; 1, 
pasty; 2, semiliquid; and 3, liquid. 
b  Standard error of the mean. 
c  Mean cumulative score calculation included all the pigs in each group. 
d  FFU, fluorescent focus forming units. Geometric mean peak titers were calculated among pigs that shed virus. 
* Proportions in the same column with different superscript letters (A, B) differ significantly (Fisher’s exact test, 
p≤0.05). 
** Means in the same column with different superscript letters (A, B, C) differ significantly (Kruskal Wallis Test, p≤0.05). 
Table 4. Clinical signs and rotavirus fecal shedding in Gn pigs after virulent HRV challenge∆ 
We reported previously that protection rates against rotavirus diarrhea are correlated with 
virus-specific intestinal IgA ASC and IFN-γ producing T cell responses at PID 28 in Gn pigs 
(Yuan et al., 1996; Yuan et al., 2008). A balanced Th1 and Th2 type response is needed for the 
optimal protective immunity against rotavirus. Although low dose LA further reduced the 
duration of diarrhea in the AttHRV-vaccinated pigs postchallenge, neither low nor high 
dose LA significantly altered protection rate against rotavirus challenge (proportions of pigs 
that were infected and developed diarrhea after challenge). Because virus-specific intestinal 
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IgA ASC responses probably play a more important role in rotavirus protective immunity 
than the IFN-γ producing CD8+ T cell responses (Yuan et al., 1996; Yuan et al., 2008), the 
effect of LA on virus-specific ASC responses also need to be taken into consideration 
regarding the differences in the protection conferred by the AttHRV vaccine with high or 
low dose LA. Although the low dose LA enhanced IFN-γ producing CD8+ T cell responses, 
it had negative effects on the serum antibody and ASC responses induced by the AttHRV 
vaccine. To improve the AttHRV vaccine efficacy, a different dose of LA (possible an 
intermediate dose) or a different probiotic strain (i.e. LGG) may be optimal to promote a 
balanced Th1 and Th2 response without increasing Treg cell responses. 
6. Conclusion 
Differential modulating effects on innate and adaptive immune responses by low dose 
versus high dose of the same LA NCFM strain were clearly demonstrated in gnotobiotic 
pigs. Low dose LA significantly enhanced the Th1 type effector T cell responses and 
decreased Treg cell functions in AttHRV-vaccinated pigs. Meanwhile, low dose LA resulted 
in a suppressed Th2 response, as evidenced by significantly reduced virus-specific ASC 
responses and serum antibody titers compared to the AttHRV only group. The dose effects 
of LA on IFN-γ producing T cell and CD4+CD25-FoxP3+ Treg cell immune responses were 
similar between the intestinal and systemic lymphoid tissues. Thus the same probiotic strain 
used in different doses can either increase or reduce mucosal and systemic immune 
responses induced by vaccines. These findings have significant implications in the use of 
probiotic lactobacilli as immunostimulatory versus immunoregulatory agents. Probiotic 
products are increasingly used to improve health, alleviate disease symptoms, and enhance 
vaccine efficacy. Our findings suggest that probiotics can be ineffective or even detrimental 
if not used at the optimal dosage for the appropriate purposes, highlighting the importance 
of not only strain but also dose selection in probiotic studies.  
The gnotobiotic pig model is a valuable animal model for study of probiotic-virus-host 
interaction because of the many similarities between human and porcine intestinal 
physiology and mucosal immune system (Meurens et al., 2012). The gnotobiotic status 
prevents confounding factors from commensal microflora that are present in conventionally 
reared animals or in humans. Unlike gnotobiotic mice, gnotobiotic pigs are devoid of 
maternal antibodies, thus providing an immunologically naïve background that allows clear 
identification of the immune responses to a single vaccine in hosts colonized with a 
qualitatively and quantitatively defined probiotic bacterial strain (Butler, 2009; Yuan & Saif, 
2002). Although data from studies of gnotobiotic animal models may not be generalized 
directly to normal animals or humans, gnotobiotic animals provide a medium in which 
investigating the complex interrelationships of the host and its associated microbes become 
possible (Coates, 1975). Our findings provide a good starting point for identification of the 
optimal dosage of a probiotic strain. But nonetheless, the optimal dosage needs to be 
confirmed in conventionalized gnotobiotic pigs and in human clinical trials in order to 
achieve the appropriate adjuvant effect for rotavirus and other vaccines. 
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